Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Medtronic
Merck
Dow
McKesson

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Prinston Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PRINSTON INC, and what generic and branded alternatives to PRINSTON INC drugs are available?

PRINSTON INC has fifty-eight approved drugs.

There are two tentative approvals on PRINSTON INC drugs.

Summary for Prinston Inc
US Patents:0
Tradenames:49
Ingredients:49
NDAs:58

Drugs and US Patents for Prinston Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 202533-002 Jul 20, 2012 AB RX No No   Start Trial   Start Trial
Prinston Inc TELMISARTAN telmisartan TABLET;ORAL 207882-002 May 3, 2017 AB RX No No   Start Trial   Start Trial
Prinston Inc METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 208880-001 Sep 10, 2018 AB1 RX No No   Start Trial   Start Trial
Prinston Inc PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 040622-002 Jul 18, 2006 AB RX No No   Start Trial   Start Trial
Prinston Inc FENOFIBRATE fenofibrate TABLET;ORAL 211080-001 Aug 28, 2018 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
AstraZeneca
Express Scripts
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.